46
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Current Concepts of the Immunobiology and Immunotherapy of Cutaneous T Cell Lymphoma: Insights Gained through Cross-talk between the Clinic and the Bench

&
Pages 1697-1703 | Published online: 01 Jul 2009

References

  • Jondal, M., Holm, G. and Wigzell, H. (1972) "Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells", Journal of Experimental Medicine 136, 207–215.
  • Broder, S., Edelson, R., Lutzner, M., Nelson, DJ., McDermott, R.P., Durn, ME., Golmas, C.K., Meade, B.D. and Waldman, T.A. (1976) "The Sezary syndrome: a malignant proliferation of helper T cells", Journal of Clinical Investigation 58, 1297–1306.
  • Berger, CL., Warburton, D., Raafat, J., LoGerfo, P. and Edelson, R.L. (1979) "Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity", Blood 4, 642–651.
  • Kung, P.C., Berger, CL., Goldstein, G., LoGerfo, P. and Edelson, R.L. (1981) "Cutaneous T-cell lymphoma: characterization by monoclonal antibodies", Blood 57, 261–266.
  • Lutzner, M.A., Edelson, R.L., Schein, P., Green, I., Kirkpatrick, C. and Aftab, A. (1975) "Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders", Annals of Internal Medicine 83, 534–552.
  • Schuler, G. and Steinman, R.M. (1985) "Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro", Journal Experimental Medicine 161, 526–546.
  • Picker, L.J., Michie, S.A., Rott, L.S. and Butcher, E.C. (1990) "A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites", American Journal of Pathology 136, 1053–1068.
  • Fuhlbrigge, R., Kieffer, J.D., Armerding, D. and Kupper, T.S. (1997) "Cutaneous lymphocyte antigen (CLA) is a specialized form of PSGL-1 on skin homing T cells", Nature 389, 78–981.
  • Dummer, R., Heald, P.W., Nestle, FO., Ludwig, E., Laine, E., Hemmi, S. and Burg, G. (1996) "Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain)", Blood 15, 1383–1389.
  • Ramsay, DL., Meller, J.A. and Zackheim, H.S. (1995) "Topical treatment of early cutaneous T-cell lymphoma", Hematology, Oncology Clinics of North America 5, 1031–1056.
  • Quiros, RA., Jones, G.W., Kacinski, B.M., Braverman, I., Heald, R.W., Edelson, R.L. and Wilson, L.D. (1997) "Total skin electron beam therapy followed by adjuvant psoralen/ulatraviolet—A light in the management of patients with Ti and T2 cutaneous T-cell lymphoma (mycosis fungoides)", International Journal of Radia-tion Oncology, Biology and Physics 38, 1027–1035.
  • Edelson, R.L., Berger, CL., Gasparro, F.P., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., McKiernan, G., Christiansen, I., Oster, M., Honigsmann, H., Wilford, H., Kokoschka, E., Rehle, T., Perez, M., Stingl, G. and Laroche, L. (1987) "Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally-photoactivated 8-methoxy-psoralen", New England Journal of Medicine 316, 297–303.
  • Zic, J.A., Stricklin, G.P., Greer, J.P., Kinney, MC., Shyr, Y, Wilson, D.C. and King, L.E. Jr (1996) "Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy", Journal of the American Academy of Dermatology 35, 935–945.
  • Jiang, S.B., Dietz, S.B., Kim, M. and Lim, H.W. (1999) "Extracorporeal photochemotherapy for cutaneous T-cell lym-phoma: a 9.7 year experience", Photodennatology, Photoimmuno-logy and Photomedicine 15, 161–165.
  • Wollina, U., Liebold, K., Kaatz, M., Looks, A., Stuhlert, A. and Lange, D. (2000) "Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemo-therapy", Oncology Reports 7, 1197–1201.
  • Crovetti, G., Carabelli, A., Berti, E., Guizzardi, M., Fossati, S., De Filippo, C. and Bertani, E. (2000) "Photopheresis in cutaneous T-cell lymphoma: five-year experience", International Journal of Artificial Organs 23, 55–62.
  • Berger, CL., Longley, B.J., Imaeda, S., Christensen, I., Heald, P. and Edelson, R.L. (1998) "Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor", International Journal of Cancer 76, 304–311.
  • Berger, CL., Wang, N., Christensen, I., Longley, J., Heald, P. and Edelson, R.L. (1996) "The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens", Journal of Investigative Dermatology 107, 392–397.
  • Girardi, M., Schechner, J., Glusac, E., Berger, C. and Edelson, R. (2002) "Transimmunization and the evolution of extracorporeal photochemotherapy", Transfusion Apheresis Science 3, 181–190.
  • Berger, CL., Xu, AL., Hanlon, D., Lee, C., Schechner, J., Glusac, E., Christensen, I., Snyder, E., Holloway, V, Tigelaar, R. and Edelson, R.L. (2001) "Induction of human tumor-loaded dendritic cells", International Journal of Cancer 4, 438–447.
  • Berger, CL., Hanlon, D., Kanada, D., Dhodapkar, M., Lombillo, V, Wang, N., Christensen, I., Howe, G., Crouch, J., El-Fishawy, P. and Edelson, R. (2002) "The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells", Blood 99, 2929–2938.
  • Nickoloff, B.J. and Griffiths, C.E.M. (1990) "Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle associated antigen (KI-67) in mycosis fungoides", American Journal of Pathology 136, 261–265.
  • Chu, A., Berger, CL., Kung, P. and Edelson, R.L. (1982) "In situ identification of Langerhans cells in the dermal infiltrate of cutaneous T cell lymphoma", Journal of the American Academy of Dermatology 3, 350–354.
  • Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245–252.
  • Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Reise, E., Sousa, C., Germain, RN., Mellman, I. and Steinman, R.M. (2000) 'The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli", Journal of Experimental Medicine 191, 927–936.
  • Feng, H., Zeng, Y, Ginner, MW., Likhacheva, A. and Katsanis, E. (2003) "Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity", Blood 101, 245–252.
  • Levings, M.K., Sangregorio, R. and Roncarolo, M.-G. (2001) "Human CD25+ CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function", Journal of Experimental Medicine 193, 1295 —1301.
  • Kingsley, CI, Karim, M., Bushell, A.R. and Wood, K.J. (2002) "CD25+ CD4+ regulatory T cells prevent graft rejection: CTLA-4 and 1L10-dependent immunoregulation of alloresponses", Journal of Immunology 168, 1080–1086.
  • Nakamura, K., Kitani, A. and Strober, W. (2001) "Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor 13", Journal of Experimental Medicine 194, 629–644.
  • Antony, P.A. and Restifo, N.P. (2002) "Commentary: do CD4+CD25+ immunoregulatory T cells hinder tumor immunothe-rapy?", Journal of Immunotherapy 25, 202–206.
  • Steinman, R.M. and Pope, M. (2002) "Exploiting dendritic cells to improve vaccine efficacy", Journal of Clinical Investigation 109, 1519–1526.
  • Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A.H. (2000) "Induction interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells", Journal of Experimental Medicine 192, 1213–1222.
  • Guntermann, C. and Alexander, D.R. (2002) "CTLA-4 suppresses proximal TCR signalirT in resting human CD4+ T cells by inhibiting ZAP-70 Tyr3'9 phosphorylation: a potential role for tyrosine phosphatases", Journal of Immunology 168, 4420–4429.
  • Berger, CL., Cohen, J., Trinh, J., Hanlon, D. and Edelson, R.L. (2002) "The growth of cutaneous T Cell lymphoma is driven by auto-antigen and regulated by CTLA-4", Journal of Investigative Dermatology 119, 296a.
  • Rook, AR, Wood, G.S., Yoo, E.K., Elenitsas, R., Kao, D.M.F., Sherman, ML., Witmer, W.K., Rockwell, K.A., Shane, R.B., Lessin, S.R. and Vonderheid, EC. (1999) "Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T cell responses", Blood 94, 902–908.
  • Prud'homme, G.J. and Piccirillo, C.A. (2000) "The inhibitory effects of transforming growth factor-beta-1 (TGF-131) in autoimmune diseases", Journal of Autoimmunity 14, 23–42.
  • Caux, C., Massacrier, D., Dubois, B., Valladeau, J., Dezuller-Dambuyant, C., Durand, I., Schmitt, D. and Saeland, S. (1999) "Respective involvement of TGF-13 and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors", Journal of Leukocyte Biology 66, 781–791.
  • Guironnet, G., Dezuter-Dambuyant, C., Vmcent, C., Bechetoille, N., Schmitt, D. and Péguet-Navarro, J. (2002) "Antagonistic effects of IL-4 and TGF-I31 on Langerhans cell-related antigen expression by human monocytes", Journal of Leukocyte Biology 71, 845–853.
  • Gilchrest, BA., Parrish, LA., Tanenbaum, L., Haynes, J.A. and Fitzpatrick, T.B. (1976) "Oral methoxsalen photochemotherapy of mycosis fungoides", Cancer 38, 683–689.
  • Chambers, CA., Kuhns, M., Egen, J.G. and Allison, J.P. (2001) "CTLA-4-medited inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy", Annual Reviews of Immunology 19, 565–594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.